Abstract |
Acute graft-versus-host disease (GVHD) is a leading cause of mortality after allogeneic hematopoietic cell transplantation (HCT) mediated by dysregulated T-cell immune reconstitution. Given the role of the T-cell immunoglobulin and mucin 1 (TIM-1) surface protein in many immune processes, including organ transplantation tolerance, we asked if TIM-1 might drive post-transplant inflammation and acute GVHD. TIM-1 binds to phosphatidylserine (PtdSer), and agonism of TIM1 on immune cells is proinflammatory. HCT conditioning results in a significant supply of PtdSer from apoptosis and cellular debris. Using murine models, treatment with an antagonistic anti-TIM-1 monoclonal antibody (mAb) protects against acute GVHD while maintaining graft-versus- tumor effects. In contrast, the addition of exogenous free PtdSer worsened GVHD in a TIM-1-dependent manner. Importantly, TIM-1 blockade did not alter the expansion of donor T cells in vitro or in vivo. Instead, TIM-1 blockade reduces proinflammatory cytokines and promotes anti-inflammatory factors like carbonic anhydrase 1 and serum amyloid A1 in the gut tissue. This is mediated by TIM-1 on donor cells, as HCT of wild-type (WT) bone marrow (BM) and conventional T (Tcon) cells into TIM-1-/- knockout (KO) recipient mice showed little survival advantage compared with WT recipients, whereas WT recipients of TIM-1-/- KO Tcon cells or TIM1-/- KO BM had improved survival, in part due to the expression of TIM-1 on donor invariant natural killer T cells, which drives inflammation. Finally, in a humanized mouse xenograft GVHD model, treatment with anti-human TIM-1 antagonist mAb reduced GVHD disease burden and mortality. This supports TIM-1 as important for GVHD pathogenesis and as a target for the prevention of GVHD.
|
Authors | Bettina P Iliopoulou, Katie Hsu, Magdiel Pérez-Cruz, Sai-Wen Tang, Wendy W Pang, Tom Erkers, Neeraja Kambham, Gordon J Freeman, Rosemarie H Dekruyff, Everett H Meyer |
Journal | Blood advances
(Blood Adv)
Vol. 3
Issue 21
Pg. 3419-3431
(11 12 2019)
ISSN: 2473-9537 [Electronic] United States |
PMID | 31714958
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | © 2019 by The American Society of Hematology. |
Chemical References |
- Antibodies, Blocking
- Antibodies, Monoclonal
- Biomarkers
- HAVCR1 protein, human
- Hepatitis A Virus Cellular Receptor 1
- Inflammation Mediators
|
Topics |
- Animals
- Antibodies, Blocking
(therapeutic use)
- Antibodies, Monoclonal
(therapeutic use)
- Biomarkers
- Disease Models, Animal
- Gene Expression
- Graft vs Host Disease
(diagnosis, drug therapy, etiology, mortality)
- Hematopoietic Stem Cell Transplantation
(adverse effects, methods)
- Hepatitis A Virus Cellular Receptor 1
(antagonists & inhibitors, genetics, metabolism)
- Humans
- Immune Reconstitution
- Immunohistochemistry
- Immunophenotyping
- Inflammation Mediators
(metabolism)
- Lymphocyte Count
- Mice
- Mice, Knockout
- Severity of Illness Index
- Survival Rate
- T-Lymphocytes
(immunology, metabolism)
- Transplantation, Homologous
|